Shandong Weigao Blood Purification Products (603014) Stock Overview
Shandong Weigao Blood Purification Products Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 603014 from our risk checks.
603014 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shandong Weigao Blood Purification Products Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥41.20 |
| 52 Week High | CN¥49.99 |
| 52 Week Low | CN¥35.00 |
| Beta | 0 |
| 1 Month Change | 0.24% |
| 3 Month Change | 6.71% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -0.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603014 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -0.4% | -0.08% | 0.4% |
| 1Y | n/a | 10.9% | 34.6% |
Return vs Industry: Insufficient data to determine how 603014 performed against the CN Medical Equipment industry.
Return vs Market: Insufficient data to determine how 603014 performed against the CN Market.
Price Volatility
| 603014 volatility | |
|---|---|
| 603014 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 603014 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603014's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Cunming Zhang | www.wego-healthcare.com |
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets.
Shandong Weigao Blood Purification Products Co., Ltd. Fundamentals Summary
| 603014 fundamental statistics | |
|---|---|
| Market cap | CN¥17.21b |
| Earnings (TTM) | CN¥474.39m |
| Revenue (TTM) | CN¥3.70b |
Is 603014 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603014 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.70b |
| Cost of Revenue | CN¥2.19b |
| Gross Profit | CN¥1.51b |
| Other Expenses | CN¥1.03b |
| Earnings | CN¥474.39m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Mar 28, 2026
| Earnings per share (EPS) | 1.14 |
| Gross Margin | 40.79% |
| Net Profit Margin | 12.84% |
| Debt/Equity Ratio | 0% |
How did 603014 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 16:00 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Weigao Blood Purification Products Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mingxin Sun | Citic Securities Co., Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |